risks of microdosing glp 1 GLP-1 for autoimmune conditions: what the research actually shows GLP-1 Microdosing - National Consumers

Ive seen this a number of times with Vyepti, for example

doi: 10.1148/radiol.2018180112 361 IshikawaKNaguraHYokotaTYamanouchiH

A realistic year-one tirzepatide spend lands around $3,500 to $4,000, and year-two maintenance at roughly $4,000 to $4,500

Furthermore, the trajectory of the weight loss curves suggested that at 48 weeks the plateau of weight was not yet reached and all the participants in the 8 and 12 mg had a weight reduction of 5% or more, which is currently the minimum threshold for efficacy [64]

If you take blood pressure medications or anticoagulants, adding peptide therapy could create complications

by 2023, TikTok videos, celebrity endorsements and a viral off-label market for Ozempic had pushed demand so high that Novo Nordisk warned of global shortages